Drug interactions
Metformin-repaglinide + Sofosbuvir / velpatasvir
Severity: Moderate
Metformin-repaglinide and Sofosbuvir / velpatasvir: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Velpatasvir inhibits OATP1B1 and other transporters and may increase repaglinide exposure. Also, improved glycemia after hepatitis C treatment can lower antidiabetic requirements, so hypoglycemia is possible.
What this interaction means in plain words
Metformin-repaglinide and Sofosbuvir / velpatasvir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Velpatasvir inhibits OATP1B1/1B3 hepatic uptake of repaglinide.
What to do
Monitor blood glucose during and after hepatitis C therapy and reduce antidiabetic doses if hypoglycemia occurs.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Metformin-repaglinide and Sofosbuvir / velpatasvir, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Metformin-repaglinide
Frequently asked questions
Can I take Metformin-repaglinide with Sofosbuvir / velpatasvir?
MediHelp rates the interaction as moderate. Metformin-repaglinide and Sofosbuvir / velpatasvir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Velpatasvir inhibits OATP1B1 and other transporters and may increase repaglinide exposure. Also, improved glycemia after hepatitis C treatment can lower antidiabetic requirements, so hypoglycemia is possible.
How serious is the interaction between Metformin-repaglinide and Sofosbuvir / velpatasvir?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose during and after hepatitis C therapy and reduce antidiabetic doses if hypoglycemia occurs.
What other medicines interact with Metformin-repaglinide?
MediHelp also lists interactions of Metformin-repaglinide with, for example, Gemfibrozil, Apalutamide, Clarithromycin. The full list is on the Metformin-repaglinide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
